Citigroup’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $593K | Buy |
|
|||||
|
2025
Q1 | $200K | Sell |
|
|||||
|
2024
Q4 | $636K | Buy |
|
|||||
|
2024
Q3 | $919K | Buy |
|
|||||
|
2024
Q2 | $415K | Sell |
|
|||||
|
2024
Q1 | $1.74M | Buy |
|
|||||
|
2023
Q4 | $483K | Sell |
|
|||||
|
2023
Q3 | $1.82M | Sell |
|
|||||
|
2023
Q2 | $29.1M | Sell |
|
|||||
|
2023
Q1 | $34M | Buy |
|
|||||
|
2022
Q4 | $26.4M | Sell |
|
|||||
|
2022
Q3 | $52M | Buy |
|
|||||
|
2022
Q2 | $42.8M | Sell |
|
|||||
|
2022
Q1 | $53.8M | Buy |
|
|||||
|
2021
Q4 | $53.5M | Buy |
|
|||||
|
2021
Q3 | $43.4M | Buy |
|
|||||
|
2021
Q2 | $2.22M | Buy |
|
|||||
|
2021
Q1 | $288K | Buy |
|
|||||
|
2020
Q4 | $19K | Buy |
|